Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3759

Regenerative Medicines Market by technology (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules & Biologics), Material (Biodegradable Synthetic Polymers, Scaffold, Hydrogel & Collagen, Transgenic, Fibroblasts, Small Molecules and Biologics) - Global Opportunity Analysis and Industry Forecast, 2015 - 2022

LI 16391
Pages: 145
Aug 2016 | 5601 Views
face gplus_n
Author's : Onkar Sumant
Tables: 73
Charts: 50
twit_n pr_n

Global Regenerative Medicines Market Overview:

Global regenerative medicines market is projected to reach $ 30,237 million by 2022. Cell therapy segment is expected to dominate the market throughout the forecast period. North America led the global market in 2015, and is expected to remain dominant during the 2015-2022.

Regenerative medicines have the ability to repair, replace, and regenerate tissues and organs affected due to injury, disease, or natural ageing process. These medicines are capable of restoring the functionality of cells & tissues and are applicable in a wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers focus on developing technologies based on biologics, genes, somatic as well as stem cells. Stem cells are capable of proliferation and differentiation owing to which they are of importance in this field. Currently, majority of treatments available for degenerative or life-threatening diseases do not provide a cure or are palliative; however, regenerative medicines have the capability to replace or regenerate the tissues and organs suffering from injury or disease. Moreover, the utilization of nano-materials in wound care, drug delivery, and immunomodulation creates growth avenues for the regenerative medicines market.

The major factors boosting the market growth include technological advancements in tissue and organ regeneration, increasing prevalence of chronic diseases and trauma emergencies, prominent potential of nanotechnology, and emergence of stem cell technology. In addition, increasing incidence of degenerative diseases and shortage of organs for transplantation are expected to boost the growth of the market. The prominent potential of regenerative medicine to replace, repair, and regenerate damaged tissues and organs has boosted the market growth. Moreover, utilization of nanomaterials in wound care, drug delivery, and immunomodulation has opened growth avenues for the regenerative medicines market. However, stringent regulatory barriers and high cost of the treatment are likely to hinder the market growth.

Top investment pockets

North America is the most attractive region in the global regenerative medicines market and is expected to be the first preference for new entrants due to the increasing end-use applications in the region. The North American regenerative medicines market is in its growing phase and is expected to exhibit high potential in future, as most of the therapies are in the 3rd phase of clinical trials. This shows the intervention of companies for commercialization of regenerative medicine products. Favorable regulatory and reimbursement policies for tissue engineering shows interest of government authorities fulfilling the growing need of regenerative products. However, stringent regulatory policies pertaining to stem cell technologies have posed major challenges for the adoption of embryonic stem cells, owing to ethical issues and controversies regarding its source; thereby, restricting the market growth. Consumer awareness regarding the benefits of regenerative medicine has increased in the recent years, which has influenced the demand. The North American regenerative market is expected to grow at a CAGR of 32.5% from 2016 to 2022. Europe is the second most attractive market for new entrants in the regenerative medicine market, which is expected to grow at a CAGR of 31.2%. Asia-Pacific region is growing at a CAGR of 39.9%.

 

Segment Review:

The regenerative medicine materials market is segmented into three broad categories, namely, synthetic materials, biologically derived materials, and genetically engineered materials. The demand for synthetic and biological derived materials is high in the market due to the presence of remarkable characteristics such as cellular adoption and higher immune response. Tissue engineering and regenerative medicine are widely used in the biomedical sector for regeneration and repair of diseased tissue or trauma tissues. Tissue regeneration can be conducted both in vitro and in vivo conditions. Tissue engineering requires artificial matrix for regeneration of tissues. This artificial matrix aids in the proliferation and differentiation of cells, leading to regeneration of tissues. The demand for synthetic tissue engineering materials is currently high due to its higher efficiency as compared to other naturally derived materials. The global market for tissue engineering generally prefers biologically derived materials, as they provide better outcome during the procedures.

Top players in the market are investing huge capital in R&D activities to develop enhanced products, in order to cater current demand. Some of the major players in the regenerative medicines market are Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Baxter International, Inc., DePuy Synthes, Organogenesis, Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Ocata Therapeutics, Inc. (Astellas Pharma, Inc.), and CryoLife, Inc.

Raw Material Analysis

The demand for biologically derived materials for regenerative medicine is currently high due to its efficiency over other naturally derived materials. During the procedures, synthetic materials are more used compared to others, as they provide better outcome during the procedures. Synthetic polymers play a key role in regenerative medicine products. Currently, novel synthetic biomaterials are developed for the use of three-dimensional extracellular microenvironments. Increase in demand for material reengineering and cell biology would result in the development of synthetic materials, which comprise necessary processes that are used in tissue and organ-specific differentiation and morphogenesis.

The recent progress in the design of synthetic materials have led to the use of hydrogel in tissue-engineered scaffolds. These synthetic materials comprises interlinked polymers that form a network-like structure through physical and chemical cross-linking. Although the synthetic materials used in tissue engineering hold promising potential in the market in terms of revenue, it may face challenges from the external market forces. Combination materials and time-sensitive use of materials are expected to be crucial factors for choosing synthetic materials in future.

Regenerative Medicines Market

KEY BENEFITS OF REGENERATIVE MEDICINES MARKET

  • The report provides an in-depth analysis of the global regenerative medicines market and future estimations, in terms value, from 2016 to 2022, including information about the current market situation, changing market dynamics, expected trends, and market intelligence.
  • The factors that drive and impede the growth of the global market are comprehensively analyzed in this study.
  • SWOT analysis highlights the internal environment of leading companies for effective strategy formulation.
  • The report contains a comprehensive study of the key strategies adopted by companies to gain traction in the market.
  • Micro-level analysis is conducted based on technology, material, application, and region.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

REGENERATIVE MEDICINES MARKET SEGMENTS

The regenerative medicines market is segmented on the basis of type, source, application, and geography.

By Technology

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Small Molecules & Biologics

By Material

  • Synthetic Materials
    • Biodegradable Synthetic Polymers
    • Scaffold
    • Artificial Vascular Graft Materials
    • Hydrogel Material
  • Biologically Derived Materials
    • Collagen
    • Xenogeneic Material
  • Genetically Engineered Materials
    • Deoxyribonucleic Acid Transfection Vectors
    • Genetically Manipulated Cells
    • Three-Dimensional Polymer Technology
    • Transgenic
    • Fibroblasts
    • Neural Stem Cells
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecules
    • Biologics

By Application

  • Cardiovascular
  • Oncology
  • Dermatology
  • Musculoskeletal
  • Wound Healing
  • Ophthalmology
  • Neurology
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • Republic of South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Competitive rivalry
3.3.5 Treat of substitutes

3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 High adoption of Stem cell technology
3.4.1.2 Emerging application of nanotechnology
3.4.1.3 Increasing prevalence of chronic diseases and trauma emergencies
3.4.1.4 Advancements in Medical Equipment technologies

3.4.2 Restraints

3.4.2.1 Complex regeneration processes
3.4.2.2 Costly treatment Associated with regenerative medicne

3.4.3 Opportunities

3.4.3.1 Lucrative opportunities of novel stem cell technologies
3.4.3.2 Increasing potential in emerging economies
3.4.3.3 Growing need of regenerative medicine in organ transplantation

Chapter: 4 WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022

4.1 Overview

4.1.1 Market size and forecast

4.2 Cell therapy

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Gene therapy

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Tissue Engineering

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

4.5 Small molecules and biologics

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

Chapter: 5 WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2015-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 Synthetic materials

5.2.1 Market size and forecast
5.2.2 Biodegradable synthetic polymers

5.2.2.1 Market size and forecast

5.2.3 Scaffold

5.2.3.1 Market size and forecast

5.2.4 Artificial vascular graft materials

5.2.4.1 Market size and forecast

5.2.5 Hydrogel material

5.2.5.1 Market size and forecast

5.3 Biologically derived materials

5.3.1 Market size and forecast
5.3.2 Collagen

5.3.2.1 Market size and forecast

5.3.3 Xenogeneic material

5.3.3.1 Market size and forecast

5.4 Genetically Engineered Materials

5.4.1 Market size and forecast
5.4.2 Deoxyribonucleic Acid Transfection Vectors

5.4.2.1 Market size and forecast

5.4.3 Genetically manipulated cells

5.4.3.1 Market size and forecast

5.4.4 Three-dimensional polymer technology

5.4.4.1 Market size and forecast

5.4.5 Transgenic

5.4.5.1 Market size and forecast

5.4.6 Fibroblasts

5.4.6.1 Market size and forecast

5.4.7 Neural stem cells

5.4.7.1 Market size and forecast

5.4.8 Gene-activated matrices

5.4.8.1 Market size and forecast

5.5 Pharmaceuticals

5.5.1 Market size and forecast
5.5.2 Small molecules

5.5.2.1 Market size and forecast

5.5.3 Biologics

5.5.3.1 Market size and forecast

Chapter: 6 WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2015-2022

6.1 Overview

6.1.1 Market size and forecast

6.2 Cardiovascular

6.2.1 Market size and forecast

6.3 Oncology

6.3.1 Market size and forecast

6.4 Dermatology

6.4.1 Market size and forecast

6.5 Musculoskeletal

6.5.1 Market size and forecast

6.6 Wound healing

6.6.1 Market size and forecast

6.7 Ophthalmology

6.7.1 Market size and forecast

6.8 Neurology

6.8.1 Market size and forecast

6.9 Other

6.9.1 Market size and forecast

Chapter: 7 WORLD REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S.

7.2.4.1 Market size and forecast

7.2.5 Canada

7.2.5.1 Market size and forecast

7.2.6 Mexico

7.2.6.1 Market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany

7.3.4.1 Market size and forecast

7.3.5 France

7.3.5.1 Market size and forecast

7.3.6 U.K.

7.3.6.1 Market size and forecast

7.3.7 Italy

7.3.7.1 Market size and forecast

7.3.8 Spain

7.3.8.1 Market size and forecast

7.3.9 Russia

7.3.9.1 Market size and forecast

7.3.10 Rest of Europe

7.3.10.1 Market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan

7.4.4.1 Market size and forecast

7.4.5 China

7.4.5.1 Market size and forecast

7.4.6 Australia

7.4.6.1 Market size and forecast

7.4.7 India

7.4.7.1 Market size and forecast

7.4.8 South Korea

7.4.8.1 Market size and forecast

7.4.9 Taiwan

7.4.9.1 Market size and forecast

7.4.10 Rest of Asia-Pacific

7.4.10.1 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil

7.5.4.1 Market size and forecast

7.5.5 Turkey

7.5.5.1 Market size and forecast

7.5.6 Venezuela

7.5.6.1 Market size and forecast

7.5.7 Saudi Arabia

7.5.7.1 Market size and forecast

7.5.8 Republic of South Africa

7.5.8.1 Market size and forecast

7.5.9 Others LAMEA

7.5.9.1 Market size and forecast

Chapter: 8 COMPANY PROFILES

8.1 Integra Lifesciences Corporation

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves and developments

8.2 Stryker Corporation

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves and developments

8.3 Acelity Holdings, Inc. (LifeCell Corporation)

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves and developments

8.4 Organogenesis Inc. (Advanced Biohealing)

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Key strategic moves and developments

8.5 Arteriocyte Medical Systems, Inc.

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Key strategic moves and developments

8.6 Athersys, Inc.

8.6.1 Company overview
8.6.2 Operating business segments
8.6.3 Business performance
8.6.4 Key strategic moves and developments

8.7 U.S. Stem Cell, Inc. (Bioheart, Inc.)

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves and developments

8.8 Zimmer Biomet Holdings, Inc. (Zimmer)

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves and developments

8.9 CryoLife, Inc.

8.9.1 Company overview
8.9.2 Operating business segments
8.9.3 Business performance
8.9.4 Key strategic moves and developments

8.10 Medtronic plc

8.10.1 Company overview
8.10.2 Operating business segments
8.10.3 Business performance
8.10.4 Key strategic moves and developments

List of Figures

FIG. 1 TOP INVESTMENT POCKETS IN WORLD REGENERATIVE MEDICINE MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP IMPACTING FACTORS: WORLD REGENERATIVE MEDICINE MARKET
FIG. 5 GROWTH IN DISEASE TREATED VS. CLINICAL TRIALS (2008-2012)
FIG. 6 WORLD REGENERATIVE MEDICINE MARKET FOR SMALL MOLECULES, 2015-2022 ($MILLION)
FIG. 7 WORLD REGENERATIVE MEDICINE MARKET FOR BIOLOGICS, 2015-2022 ($MILLION)
FIG. 8 U.S. REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 9 CANADA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 10 MEXICO REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 11 GERMANY REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 12 FRANCE REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 13 UK REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 14 ITALY REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 15 SPAIN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 16 RUSSIAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 17 REST OF EUROPE REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 18 JAPAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 19 CHINA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 20 AUSTRALIA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 21 INDIAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 22 SOUTH KOREA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION
FIG. 23 TAIWAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 24 REST OF ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 25 BRAZIL REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 26 TURKEY REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 27 VENEZUELA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 28 SAUDI ARABIA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 29 REPUBLIC OF SOUTH AFRICA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 30 OTHER REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 31 INTEGRA LIFESCIENCES: REVENUE, 2013-2015 ($MILLION)
FIG. 32 INTEGRA LIFESCIENCES: REVENUE, BY SEGMENT, 2015 (%)
FIG. 33 INTEGRA LIFESCIENCES: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 34 STRYKER CORPORATION: REVENUE, 2013-2015 ($MILLION)
FIG. 35 STRYKER CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
FIG. 36 STRYKER CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 37 ACELITY: REVENUE, 2013-2015 ($MILLION)
FIG. 38 ACELITY: REVENUE, BY SEGMENT, 2015 (%)
FIG. 39 ACELITY: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 40 ATHERSYS: REVENUE, 2013-2015 ($MILLION)
FIG. 41 US STEM CELL: REVENUE, 2013-2015 ($MILLION)
FIG. 42 ZIMMER BIOMET: REVENUE, 2013-2015 ($MILLION)
FIG. 43 ZIMMER BIOMET: REVENUE, BY SEGMENT, 2015 (%)
FIG. 44 ZIMMER BIOMET: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 CRYOLIFE: REVENUE, 2013-2015 ($MILLION)
FIG. 47 CRYOLIFE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 MEDTRONIC: REVENUE, 2013-2015 ($MILLION)
FIG. 49 MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
FIG. 50 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 UNINTENTIONAL INJURIES FACTS (2013)
TABLE 2 TRENDS IN REGENERATIVE MEDICINE INDUSTRY (2007-2011)
TABLE 3 WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 4 WORLD REGENERATIVE MEDICINE MARKET FOR CELL THERAPY, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 5 WORLD REGENERATIVE MEDICINE MARKET FOR GENE THERAPY, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 6 WORLD REGENERATIVE MEDICINE MARKET FOR TISSUE ENGINEERING, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 7 WORLD REGENERATIVE MEDICINE MARKET FOR SMALL MOLECULES AND BIOLOGICS, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 8 WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2015-2022 ($MILLION)
TABLE 9 WORLD REGENRATIVE MEDICINE MARKET FOR SYNTHETIC MATERIALS, 2015-2022 ($MILLION)
TABLE 10 WORLD SYNTHETIC MATERIAL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 CLASSIFICATION OF BIODEGRADABLE POLYMERS
TABLE 12 WORLD BIODEGRADABLE SYNTHETIC POLYMERS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 LIST OF COMMERCIAL POLYMERIC SCAFFOLDS PRODUCTS
TABLE 14 WORLD SCAFFOLD MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 15 WORLD ARTIFICIAL VASCULAR GRAFT MATERIALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD HYDROGEL MATERIAL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 17 WORLD REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIALS, 2015-2022 ($MILLION)
TABLE 18 WORLD BIOLOGICALLY DERIVED MATERIALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 19 WORLD COLLAGEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 20 WORLD XENOGENEIC MATERIAL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 21 WORLD REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIALS, 2015-2022 ($MILLION)
TABLE 22 WORLD GENETICALLY ENGINEERED MATERIALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 23 WORLD DEOXYRIBONUCLEIC ACID TRANSFECTION VECTORS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 24 WORLD GENETICALLY MANIPULATED CELLS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 25 WORLD THREE-DIMENSIONAL POLYMER TECHNOLOGY MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26 WORLD TRANSGENIC MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 27 WORLD FIBROBLASTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 28 WORLD NEURAL STEM CELLS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 29 WORLD GENE-ACTIVATED MATRICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 30 WORLD REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, 2015-2022 ($MILLION)
TABLE 31 WORLD PHARMACEUTICALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 32 WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2015-2022 ($MILLION)
TABLE 33 WORLD CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 34 WORLD ONCOLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 35 STATISTICS FOR SKIN DAMAGE MEDICAL CONDITIONS IN THE U.S. AND WORLDWIDE, 2011
TABLE 36 LIST OF ACELLULAR SKIN TISSUE-ENGINEERED PRODUCTS IN THE MARKET
TABLE 37 LIST OF CELLULAR SKIN TISSUE-ENGINEERED PRODUCTS IN THE MARKET
TABLE 38 WORLD DERMATOLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 39 STATISTICS FOR BONE DAMAGE AND RELATED DISEASES, 2011
TABLE 40 STATISTICS FOR CARTILAGE DAMAGE WORLDWIDE
TABLE 41 WORLD MUSCULOSKELETAL APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 42 WORLD WOUND HEALING APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 43 WORLD OPHTHALMOLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 44 WORLD NEUROLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 45 WORLD OTHER APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 46 WORLD REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 47 NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 48 NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 49 EUROPEAN REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 50 EUROPEAN REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 51 ASIAPACIFIC REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 52 ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 53 LAMEA REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 54 LAMEA REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 55 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 56 INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 57 STRYKER: COMPANY SNAPSHOT
TABLE 58 STRYKER: OPERATING SEGMENTS
TABLE 59 ACELITY: COMPANY SNAPSHOT
TABLE 60 ACELITY: OPERATING SEGMENTS
TABLE 61 ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 62 ORGANOGENESIS, INC.: PRODUCT SEGMENT
TABLE 63 ARTERIOCYTE: COMPANY SNAPSHOT
TABLE 64 ARTERIOCYTE: OPERATING SEGMENT
TABLE 65 ATHERSYS: COMPANY SNAPSHOT
TABLE 66 ATHERSYS: OPERATING SEGMENTS
TABLE 67 US STEM CELL: COMPANY SNAPSHOT
TABLE 68 ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 69 ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 70 CRYOLIFE: COMPANY SNAPSHOT
TABLE 71 CRYOLIFE: OPERATING SEGMENTS
TABLE 72 MEDTRONIC: COMPANY SNAPSHOT
TABLE 73 MEDTRONIC: OPERATING SEGMENTS

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts